Biomedican – organic biosynthesis of rare cannabinoids

The cannabinoids market is growing exponentially to reach 146 billion dollars by 2026. Learn how you can benefit from this opportunity. Visit http://biomedican.com/

Cannabis is not smoke for hippies anymore. Scientists found over 200 unique compounds in the cannabis plant, most of which have no intoxicating effect. Instead, they offer substantial health benefits and treat many medical conditions, including diabetes, oncology, epilepsies, pain, and many others. There is also an increasing demand for cannabinoids in the food and veterinary industry, hygienic, and cosmetic products.

However, this demand could not be satisfied until now. The most valuable cannabinoids, such as CBG, CBGA, CBN, CBNA, THCB, THCVA, THCA, are called rare cannabinoids since they exist in the cannabis plant in tiny amounts, and their extraction used to be too expensive.

Biomedican is a biotech company that solved this problem. Our Ph.D. scientists use the revolutionary method of organic biosynthesis to meet the demand for rare cannabinoids. We produce pharmaceutical-grade, 100% organic, non-GMO rare cannabinoids (CBG, CBGA, and others) at a 70-90% lower cost.

source